- Home
- INGN
INGN
Inogen Inc
as 12-18-2024 12:38pm EST
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | GOLETA |
| Market Cap: | 212.5M | IPO Year: | 2014 |
| Target Price: | $7.00 | AVG Volume (30 days): | 170.4K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.24 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.08 - $13.33 | Next Earning Date: | 11-07-2024 |
| Revenue: | $331,520,000 | Revenue Growth: | 1.12% |
| Revenue Growth (this year): | 6.51% | Revenue Growth (next year): | 4.24% |
Latest Inogen Inc News
INGN Breaking Stock News: Dive into INGN Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen
Zacks
7 days ago
5 Medical Device Stocks That Survived the 2024 Market Volatility
Zacks
23 days ago
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Zacks
a month ago
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up
Simply Wall St.
a month ago
US$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results
Simply Wall St.
a month ago
Inogen Third Quarter 2024 Earnings: Beats Expectations
Zacks
a month ago
Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say
GuruFocus.com
a month ago
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges
Compare INGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INGN Inogen Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.